RecruitingNot ApplicableNCT06163781

Appropriate Use of Blood Cultures in the Emergency Department Through Machine Learning

Appropriate Use of Blood Cultures in the Emergency Department Through Machine Learning: a Randomized Controlled Trial


Sponsor

Amsterdam UMC, location VUmc

Enrollment

7,584 participants

Start Date

Feb 19, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to study whether the use of our blood culture prediction tool is non-inferior to current practice and if it can improve certain outcomes in all adult patients presenting to the emergency department with a clinical indication for a blood culture analysis (according to the treating physician). The primary endpoint is 30-day mortality. Key secondary outcomes are: * hospital admission rates * in-hospital mortality * hospital length-of-stay. In the intervention group, the physician will follow the advice of our blood culture prediction tool. In the comparison group all patients will undergo a blood culture analysis.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Blood culture prediction tool for people with artificial intelligence, emergency service, hospital, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBlood culture prediction tool

Machine learning based predicition tool


Locations(1)

Amsterdam UMC - location AMC

Amsterdam, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06163781


Related Trials